CAS 1169755-45-6

INDY

CAS: 1169755-45-6

Fórmula: C₁₂H₁₃NO₂S

Pureza: 98%

Peso molecular: 235.3021

Ref: IN-DA0096WU

INDY

CAS: 1169755-45-6

INDY

Pureza: ≥98%

Peso molecular: 235.3g/mol

Ref: 54-BUP10325

INDY

CAS: 1169755-45-6

Ref: 7W-GW1194

Indy

CAS: 1169755-45-6

Indy is a drug used to treat metabolic disorders such as hepatic steatosis. Sodium citrate is an ion that regulates the acidity of body fluids, which helps maintain the balance of water and electrolytes in the body. It also has a role in regulating blood pH and preventing kidney stone formation. The uptake of sodium citrate occurs mainly through active transport by renal cells and liver cells. When taken orally, it is absorbed from the intestines into the bloodstream, where it binds with phosphates to form citric acid, which can be broken down by enzymatic reactions to release carbon dioxide and water. This breakdown process generates energy, which is then stored in the form of adenosine triphosphate (ATP). Citrate also has a potential target for drug development due to its effects on fatty acids and atp levels in humans.

Fórmula: C₁₂H₁₃NO₂S

Pureza: Min. 95%

Peso molecular: 235.3 g/mol

Ref: 3D-UWB75545

INDY

CAS: 1169755-45-6

INDY is an ATP-competitive inhibitor of Dyrk1A and Dyrk1B with IC50s of 0.24 μM and 0.23 μM and a Ki of 0.18 μM for Dyrk1A ATP pocket, respectively.

Fórmula: C₁₂H₁₃NO₂S

Pureza: 99.26%

Cor e Forma: Solid

Peso molecular: 235.3

Ref: TM-T15579